Abbott Completes Separation of Research-Based Pharmaceuticals Business
date:Jan 04, 2013
y-leading growth, expanding margins and strong cash flow. The company's businesses are aligned with long-term health trends, including the world's aging population, increasing prevalence of chronic disease, and improving access to care in fast-growing economies. Continued investment in new technologies is advancing Abbott's offerings in vascular health, diabetes care, diagnostic screening and detection, vision correction and nutrition science.

Revenue among Abbott's businesses is well balanced
6/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/06 12:59